Contact
searchSearch
HMP Global
Login

November 2018 (Supplement)

Feature

Special Article
The State of Clinical Pathways: Results From the Inaugural Journal of Clinical Pathways Benchmarking Survey
11/15/2019
Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...
Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...
...
11/15/2019
Journal of Clinical Pathways

News

Conference Coverage
Clinical Pathways for Ovarian Cancer
11/15/2019
JCP Editors
For ovarian cancer, in which treatment recurrence is a challenge and long-term maintenance therapy is often required, the clinical and financial implications of long-term treatment may differ from those of other...
For ovarian cancer, in which treatment recurrence is a challenge and long-term maintenance therapy is often required, the clinical and financial implications of long-term treatment may differ from those of other...
For...
11/15/2019
Journal of Clinical Pathways
Conference Coverage
Highlighted Presentations from the 2018 Clinical Pathways Congress
11/15/2019
JCP Editors
Pros and Cons of Vendor- and Provider-Developed Pathways On Day 1 of the 2018 Clinical Pathways Congress, Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center (New York, NY), and Robin T. Zon, MD, FACP,...
Pros and Cons of Vendor- and Provider-Developed Pathways On Day 1 of the 2018 Clinical Pathways Congress, Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center (New York, NY), and Robin T. Zon, MD, FACP,...
Pros...
11/15/2019
Journal of Clinical Pathways

Insights

Interview
Pathways in an Evolving Treatment Landscape
11/15/2019
JCP Editors
Clinical pathways are prone to criticisms that they do not take patient diversity or the latest clinical advances into account, both of which can be addressed through comprehensive pathway design and updating...
Clinical pathways are prone to criticisms that they do not take patient diversity or the latest clinical advances into account, both of which can be addressed through comprehensive pathway design and updating...
...
11/15/2019
Journal of Clinical Pathways
Interview
Harnessing the Potential of Real-World Data to Support Clinical Pathways
11/15/2019
JCP Editors
Current clinical pathways are largely based on generalized measures such as evidence-based guidelines and consensus best practices. Yet electronic medical records (EMRs) contain a tremendous amount of data that, when...
Current clinical pathways are largely based on generalized measures such as evidence-based guidelines and consensus best practices. Yet electronic medical records (EMRs) contain a tremendous amount of data that, when...
...
11/15/2019
Journal of Clinical Pathways
Interview
Individualizing Treatment Within Clinical Pathways for Multiple Myeloma
11/15/2019
JCP Editors
Standardizing treatment options for relapsed/refractory multiple myeloma poses a challenge to clinical pathway decision-makers, due to the need to individualize treatment decisions for the patient’s specific...
Standardizing treatment options for relapsed/refractory multiple myeloma poses a challenge to clinical pathway decision-makers, due to the need to individualize treatment decisions for the patient’s specific...
...
11/15/2019
Journal of Clinical Pathways
Interview
An Oncology Pathways Pioneer Paves the Way for Pathways Across Medicine
11/15/2019
JCP Editors
In 2012, Dr Barbara L. McAneny was awarded a $19.76 million grant by the Center for Medicare & Medicaid Innovation to develop the Community Oncology Medical Home (COME HOME) model and implement that model in...
In 2012, Dr Barbara L. McAneny was awarded a $19.76 million grant by the Center for Medicare & Medicaid Innovation to develop the Community Oncology Medical Home (COME HOME) model and implement that model in...
In...
11/15/2019
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use